Biggest Gainers on the NAS YTD 2025

February 09, 2025

Biggest Gainers

The biggest gainers in this list have seen their share price grow at a faster rate than the rest of the market so far this year. Stocks that are experiencing dramatic increases in share price can do so for a variety of reasons, including the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

About the Data

This table includes the top companies based on their percentage increase in share price year to date.

How do you use this table?

The biggest gainers are companies with upward momentum and potentially higher reward, but with increased risk. These stocks tend to have a higher trading volume and visibility in the marketplace. Stocks in this group can change direction quickly and tend to be short term trades. Stocks in this category are generally held for speculation or growth.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameTotal ReturnPeriod
WLGS WANG & LEE Group Inc 381.59 YTD
IVVD Invivyd Inc 360.39 YTD
DWTX Dogwood Therapeutics Inc 331.33 YTD
NITO N2OFF Inc 323.39 YTD
LTRY Lottery.com Inc 230.58 YTD
RPID Rapid Micro Biosystems Inc 228.89 YTD
DOMH Dominari Holdings Inc 227.10 YTD
QNTM Quantum BioPharma Ltd 207.61 YTD
REBN Reborn Coffee Inc 204.22 YTD
RNAZ TransCode Therapeutics Inc 192.58 YTD
All data provided as at market close February 06, 2025.

Company Details

WANG & LEE Group Inc

WLGS:NAS

Total Return

381.59

Period

YTD

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

Access the stockcalc valuation


Invivyd Inc

IVVD:NAS

Total Return

360.39

Period

YTD

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19.

Access the stockcalc valuation


Dogwood Therapeutics Inc

DWTX:NAS

Total Return

331.33

Period

YTD

Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC).

Access the stockcalc valuation


N2OFF Inc

NITO:NAS

Total Return

323.39

Period

YTD

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Lottery.com Inc

LTRY:NAS

Total Return

230.58

Period

YTD

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S.

Access the stockcalc valuation


Rapid Micro Biosystems Inc

RPID:NAS

Total Return

228.89

Period

YTD

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe.

Access the stockcalc valuation


Dominari Holdings Inc

DOMH:NAS

Total Return

227.10

Period

YTD

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Access the stockcalc valuation


Quantum BioPharma Ltd

QNTM:NAS

Total Return

207.61

Period

YTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders.

Access the stockcalc valuation


Reborn Coffee Inc

REBN:NAS

Total Return

204.22

Period

YTD

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Access the stockcalc valuation


TransCode Therapeutics Inc

RNAZ:NAS

Total Return

192.58

Period

YTD

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
WANG & LEE Group and Invivyd were the biggest gainers on the NAS YTD. See all the biggest gainers on the blog: https://www.stockcalc.com/Blog/biggest-gainers-nas-ytd-2025
WANG & LEE Group $WLGS and Invivyd $IVVD were the biggest gainers on the #NAS YTD. See the full list of gainers: https://www.stockcalc.com/Blog/biggest-gainers-nas-ytd-2025
WANG & LEE Group and Invivyd were the biggest gainers on the NAS YTD. See all the biggest gainers on the blog: https://www.stockcalc.com/Blog/biggest-gainers-nas-ytd-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.